scholarly journals Differences in T-cell immunity toward tumor-associated antigens in colorectal cancer and breast cancer patients

2003 ◽  
Vol 105 (2) ◽  
pp. 221-225 ◽  
Author(s):  
Dirk Nagorsen ◽  
Carmen Scheibenbogen ◽  
Gerhard Schaller ◽  
Binta Leigh ◽  
Alexander Schmittel ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Colorectal Cancer ◽  
T Cell ◽  
Cancer Patients ◽  
T Cell Immunity ◽  
Breast Cancer Patients ◽  
Tumor Associated Antigens ◽  
Cell Immunity

Pre-existing T-cell immunity against mucin-1 in breast cancer patients and healthy volunteers

2005 ◽  
Vol 132 (4) ◽  
pp. 265-274 ◽  
Author(s):  
Brigitte Gückel ◽  
Christine Rentzsch ◽  
Maria-Dorothea Nastke ◽  
Alexander Marmé ◽  
Ines Gruber ◽  
...  
Keyword(s):  
Breast Cancer ◽  
T Cell ◽  
Healthy Volunteers ◽  
Cancer Patients ◽  
T Cell Immunity ◽  
Breast Cancer Patients ◽  
Mucin 1 ◽  
Cell Immunity

scholarly journals Analysis of the Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine in Breast Cancer Patients Treated With Cyclin-Dependent Kinases 4 and 6 Inhibitors (CDKi): Limited T-Cell Immunity Despite Satisfactory Humoral Response.

2021 ◽  
Author(s):  
Cristina Saavedra ◽  
Alejandro Vallejo ◽  
Federico Longo ◽  
Juan José Serrano ◽  
María Fernández ◽  
...  
Keyword(s):  
Breast Cancer ◽  
T Cell ◽  
Cancer Patients ◽  
Humoral Response ◽  
T Cell Immunity ◽  
Breast Cancer Patients ◽  
Cyclin Dependent Kinases ◽  
Cell Immunity ◽  
Chemotherapy Patients ◽  
A Prospective Study

Abstract SARS-CoV-2 vaccination in cancer patients has become crucial because of their higher risk of complications and death from COVID19. We performed a prospective study to assess the immunogenicity of SARS-CoV-2 vaccine in cancer patients treated with CDKi and compared their immune response with patients treated with chemotherapy. While a robust humoral response was observed in the CDKi patients compared with chemotherapy patients, limited T-cell immunity was achieved in both groups.

Sign in / Sign up

Export Citation Format

Share Document